KPTI

Karyopharm Therapeutics (KPTI)

About Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Details

Daily high

$6.50

Daily low

$5.14

Price at open

52 Week High

$10.99

52 Week Low

$3.51

Market cap

99.8M

Dividend yield

0.00%

Volume

4,719

Avg. volume

1.6M

P/E ratio

-.33

Karyopharm Therapeutics News